Clinical Commander

All dossiers
cardio.cardiac-tamponade.post-rfa-iatrogenic.v1

Cardiac tamponade — post-RF ablation iatrogenic (PVI / atypical-flutter / steam-pop)

cardiologyacuteadultacuteinpatienttransitionoutpatient
Start encounter →Print handoutPRODUCTION

Phase E variant of cardio.cardiac-tamponade.core.v1 — narrowed to post-RF ablation iatrogenic tamponade (PVI for AF, atypical-flutter ablation, CTI ablation). Mechanism distribution per Cappato 2010 (PMID 19996100) + 2013 (PMID 23588631) worldwide AF ablation registries: direct LA wall perforation (most common ~40-50%), transseptal puncture complication, steam pop, HPSD pop, PV perforation, RA perforation. Incidence of acute tamponade complicating AF ablation 0.9-1.3%; mortality with prompt drainage 3-6%, with delay >30%. Specializes for: ICE-guided perforation site identification (Class I per HRS/EHRA 2017 PMID 28506916; TEE adjunct); protamine reversal of intra-procedural UFH (ACT 300-400 maintained during PVI); pre-procedural DOAC reversal (idarucizumab for dabigatran per RE-VERSE AD PMID 28793172, andexanet for FXa-DOACs per ANNEXA-4 PMID 30730782); cardiothoracic surgery activation if persistent bleeding > 200 mL/h or large defect; delayed AEF screen window (4-6 wk if posterior LA ablation; mortality >50%; AVOID endoscopy due to air embolism risk; CT chest with PO contrast preferred per Mansour HeartRhythm 2018). Sister-differentiated from cardio.cardiac-tamponade.post-procedural.v1 (broader iatrogenic — post-PCI, post-pacer/ICD lead, post-cardiac-surgery, post-trauma) and from cardio.cardiac-tamponade.post-tavr.v1 (transcatheter valve specific — annulus rupture, valve embolization, LV apex perforation, RV pacing-wire perforation). Manifest pointer reuses cardio.cardiac-tamponade.core.v1 manifest. Design-brief pointer reuses parent (post-RF-ablation-specific differences documented inline). Status INTEGRATED until terminology + RxNav-validated reversal-agent codes are reconciled. Authored 2026-05-15 by shard-06-cardio-acute.

Entry points (6)

  • history
    Intra-procedural hypotension/bradycardia/arrest in EP lab during PVI, transseptal puncture, or LA mapping → catheter perforation; STAT ICE for confirmation (HRS/EHRA 2017 PMID 28506916; Cappato CARE 2013 PMID 23588631)
    intra_procedural_decompensation_during_pvi
  • history
    Audible "steam pop" at ablation tip with sudden ICE artifact + impedance drop + new hemodynamic instability → micro-perforation + intramural hemorrhage extending to pericardium (HRS/EHRA 2017)
    audible_steam_pop_with_decompensation
  • history
    Post-PVI hemodynamic decompensation within first 24h → late perforation or delayed bleeding (Cappato 2013 PMID 23588631)
    post_pvi_decompensation_in_first_24h
  • imaging
    New pericardial effusion on intra-procedural ICE or post-PVI echo with hemodynamic concern (HRS/EHRA 2017 Class I monitoring)
    ice_or_tee_new_pericardial_effusion_intra_or_post_pvi
  • history
    Transseptal puncture complication — needle/sheath through aortic root, posterior LA wall, or coronary sinus → emergent recognition + drainage + cardiothoracic activation (Calkins HeartRhythm 2017 PMID 28506916)
    transseptal_puncture_complication
  • history
    Delayed (4-6 wk post-PVI) presentation with fever + neurologic symptoms + chest pain → atrioesophageal fistula screen — distinct catastrophic complication, route per esophageal pathway (Mansour HeartRhythm 2018; HRS/EHRA 2017 §AEF)
    delayed_atrioesophageal_fistula_signs_4_to_6_wk_post_pvi

Required inputs (10)

  • agerequired
    demographic • used at CONTEXT
    Older AF ablation patients have higher complication risk + worse outcomes (Cappato 2013)
  • sbprequired
    vital • used at RED_FLAGS
    Hypotension is part of Beck triad; rapid accumulation in EP-lab setting (heparinized) produces tamponade at small volumes (Spodick Circulation 2003)
  • hrrequired
    vital • used at CONTEXT
    Compensatory tachycardia in tamponade physiology (ESC 2015)
  • ice_intra_proceduralrequired
    imaging • used at INITIAL_WORKUP
    Intracardiac echo (ICE) is the standard intra-procedural imaging in modern EP labs — perforation site localization, tamponade physiology assessment, and guidance for pericardiocentesis (HRS/EHRA 2017 PMID 28506916 Class I)
  • tee_adjunct_if_posterior_la_or_unclear_icerequired
    imaging • used at INITIAL_WORKUP
    TEE adjunct when ICE view is suboptimal (posterior LA, LA appendage, transseptal complication); also used for post-procedural confirmation if delayed presentation (HRS/EHRA 2017)
  • procedural_anticoagulation_status_actrequired
    history • used at CONTEXT
    PVI requires UFH with ACT 300-400 to prevent catheter thrombus; protamine reversal drives bleeding control upon perforation (HRS/EHRA 2017 PMID 28506916; Bhatt 2018)
  • pre_procedural_anticoagulationrequired
    history • used at CONTEXT
    AF ablation patients on uninterrupted DOAC or warfarin pre-procedure — pre-procedure status drives reversal strategy (Calkins HeartRhythm 2017; Bhatt 2018)
  • hemoglobinrequired
    lab • used at INITIAL_WORKUP
    Hemorrhagic loss quantification + transfusion threshold (ESC 2015)
  • inrrequired
    lab • used at INITIAL_WORKUP
    Coagulopathy quantification for warfarin reversal (Bhatt 2018)
  • creatininerequired
    lab • used at CONTEXT
    Race-free eGFR (Inker NEJM 2021) gates DOAC dosing + andexanet/idarucizumab dosing + contrast in re-imaging

12-phase flow (10)

  1. 1FRAME
    Post-RF ablation tamponade — emergent pericardiocentesis + STAT ICE/TEE for perforation site + protamine reversal of procedural UFH + simultaneous cardiothoracic surgery activation if large defect (HRS/EHRA 2017 PMID 28506916; ESC 2015 §Iatrogenic)
    inputs: sbp
    advance: EP-lab-context tamponade physiology suspected
  2. 2ENTRY
    Recognize intra-procedural decompensation in EP lab (during PVI / transseptal / LA mapping) OR within 24h post-procedure; recognize steam-pop signature (audible pop + ICE artifact + impedance drop); activate cardiothoracic surgery for large LA tear or unstable bleeding (Cappato 2013 PMID 23588631)
    inputs: age
    advance: EP-lab-context decompensation confirmed
  3. 3CONTEXT
    Document procedure type (PVI vs atypical-flutter vs CTI), ablation modality (RF vs HPSD vs cryo), transseptal vs retrograde, intra-procedural ACT, pre-procedural anticoagulation regimen, esophageal temperature monitoring use, posterior LA ablation extent (HRS/EHRA 2017)
    inputs: procedural_anticoagulation_status_act, pre_procedural_anticoagulation
    advance: EP-lab context fully captured
  4. 4RED_FLAGS
    Obstructive shock physiology — heparinized state (ACT 300-400) means small effusion can produce tamponade (Spodick 2003); transseptal complication may involve aortic root → distinct surgical urgency; persistent bleeding despite drainage indicates large LA tear requiring open repair (HRS/EHRA 2017)
    inputs: sbp, hr
    advance: shock recognized → emergent drainage prepared with cardiothoracic surgery on standby
  5. 5INITIAL_WORKUP
    STAT ICE in EP lab (often already in place); TEE adjunct if posterior LA or transseptal complication suspected; ECG, CXR (post-drain catheter position), troponin, BMP, type & cross 4 units PRBC, coags (PT/INR, aPTT, fibrinogen, anti-Xa if DOAC pre-procedure, PT-aPTT mixing if needed), CBC; fluoroscopy of catheter positions for perforation site identification (HRS/EHRA 2017; ESC 2015)
    inputs: ice_intra_procedural, tee_adjunct_if_posterior_la_or_unclear_ice, inr, hemoglobin
    actions: panel.cardiac, panel.coag, panel.cbc
    advance: ICE/TEE confirms tamponade physiology + perforation site localized + bleeding burden quantified
  6. 6DIFFERENTIAL
    Direct catheter perforation (most common — LA wall, LA appendage, dome, posterior LA) vs transseptal complication (aortic root, posterior LA, coronary sinus) vs steam-pop micro-perforation vs HPSD pop vs PV perforation vs RA perforation; rule out atrioesophageal fistula if delayed presentation (Cappato 2013; Mansour 2018)
    advance: perforation source identified or under active investigation
  7. 7TREATMENT
    Step 1: STAT pericardiocentesis (echo or fluoroscopy guided; subxiphoid approach standard; can be done in EP lab with existing fluoroscopy); Step 2: protamine reversal of procedural UFH (1 mg per 100 U residual UFH, max 50 mg single dose); Step 3: pre-procedural anticoagulation reversal (vit K + 4F-PCC for warfarin, idarucizumab for dabigatran, andexanet for FXa-DOACs); Step 4: cardiothoracic surgery activation if persistent bleeding > 200 mL/h or large defect; Step 5: hold oral anticoagulation until bleeding controlled then re-initiate per indication 24-48h post-bleeding-control (HRS/EHRA 2017; Bhatt 2018; Pollack 2017; Connolly 2019)
    inputs: sbp
    advance: drainage performed + reversal initiated + surgical disposition determined
  8. 8DISPOSITION
    CCU/ICU post-drain; cardiothoracic surgery for surgical exploration if persistent bleeding (large LA tear); consider TEE-guided closure if small defect with rapid sealing (HRS/EHRA 2017)
    advance: multidisciplinary disposition confirmed
  9. 9MONITORING
    Re-accumulation surveillance (echo q4-6h × 24h then q12-24h × 48h); serial Hb; coagulation correction tracking; continued telemetry (post-PVI patient may have peri-procedural AF); esophageal temperature trend if posterior LA ablation; baseline esophageal screen (CT or endoscopy if posterior LA ablation extensive — though most centers reserve for symptomatic AEF screen) (HRS/EHRA 2017; Mansour 2018)
    actions: panel.cardiac
    advance: bleeding controlled + no re-accumulation × 48h + esophageal surveillance plan documented
  10. 10FOLLOWUP
    Cardiology + EP follow-up; echo at 1 wk + 1 mo to confirm resolution; AEF surveillance for 4-6 wk if posterior LA ablation (fever + neurologic symptoms + dysphagia/odynophagia → emergent CT chest with PO contrast or MRI to rule out AEF, mortality >50%; HRS/EHRA 2017 §AEF; Mansour 2018); anticoagulation re-initiation per AF-stroke-risk indication (CHA2DS2-VASc)
    advance: late-complication surveillance scheduled, AEF window covered, AF rhythm follow-up booked